• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑热病后皮肤利什曼病:肯尼亚的经验

Post kala-azar dermal leishmaniasis: the Kenyan experience.

作者信息

Muigai R, Gachihi G S, Oster C N, Were J B, Nyakundi P M, Chunge C N, Kirigi G, Rashid J R

机构信息

Clinical Research Centre, Kenya Medical Research Institute, Nairobi.

出版信息

East Afr Med J. 1991 Oct;68(10):801-6.

PMID:1667521
Abstract

Post kala-azar dermal leishmaniasis (PKDL) occurs occasionally after successful cure of visceral leishmaniasis. Twelve patients with diagnosis consistent with PKDL were seen at Clinical Research Centre from 1981 to 1985. Clinical presentation ranged from macular hypopigmented lesion to generalized nodular lesions. All lesions cleared either by self-cure or by treatment with sodium stibogluconate.

摘要

黑热病后皮肤利什曼病(PKDL)偶尔会在内脏利什曼病成功治愈后出现。1981年至1985年期间,临床研究中心共接诊了12例诊断符合PKDL的患者。临床表现从斑状色素减退性病变到全身性结节性病变不等。所有病变均通过自愈或使用葡萄糖酸锑钠治疗而消退。

相似文献

1
Post kala-azar dermal leishmaniasis: the Kenyan experience.黑热病后皮肤利什曼病:肯尼亚的经验
East Afr Med J. 1991 Oct;68(10):801-6.
2
Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.黑热病后皮肤利什曼病(PKDL):尼泊尔的首例病例报告。
Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):22-3.
3
Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya.在肯尼亚,内脏利什曼病治愈很久后出现的黑热病后皮肤利什曼病。
East Afr Med J. 1986 May;63(5):365-71.
4
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.成功治疗一名来自西欧的、患有多重复发性利什曼病的HIV感染患者的黑热病后皮肤利什曼病(PKDL)。
J Infect. 2006 Jul;53(1):e25-7. doi: 10.1016/j.jinf.2005.09.015. Epub 2005 Nov 7.
5
Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.伴有内脏利什曼病的黑热病后皮肤利什曼病:一种罕见表现。
Int J Dermatol. 2005 Jun;44(6):494-6. doi: 10.1111/j.1365-4632.2004.02433.x.
6
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.简短报告:米替福新治疗内脏利什曼病后出现的黑热病后皮肤利什曼病(PKDL)
Am J Trop Med Hyg. 2009 Mar;80(3):336-8.
7
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.口服米替福新治愈对锑无反应的印度黑热病后皮肤利什曼病
Trans R Soc Trop Med Hyg. 2006 Jul;100(7):698-700. doi: 10.1016/j.trstmh.2005.09.015. Epub 2005 Dec 2.
8
Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.苏丹的黑热病后皮肤利什曼病:临床特征、病理学及治疗
Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):245-8. doi: 10.1016/0035-9203(92)90294-m.
9
Post-kala-azar dermal leishmaniasis mimicking leprosy: experience with 4 patients, with some unusual features in 1.类麻风型黑热病后皮肤利什曼病:4例患者的经验,其中1例有一些不寻常特征
Lepr Rev. 1995 Sep;66(3):250-6. doi: 10.5935/0305-7518.19950029.
10
A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.静脉注射葡萄糖酸锑钠单独及与别嘌醇、利福平及免疫调节剂联合治疗印度型黑热病皮肤利什曼病的回顾性研究。
Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):138-44. doi: 10.4103/0378-6323.60553.

引用本文的文献

1
A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.苏丹南部葡萄糖酸锑钠单药治疗与葡萄糖酸锑钠联合巴龙霉素治疗重症黑热病后皮肤利什曼病有效性的比较——一项回顾性队列研究
PLoS One. 2016 Sep 22;11(9):e0163047. doi: 10.1371/journal.pone.0163047. eCollection 2016.
2
Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.印度黑热病后皮肤利什曼病(PKDL)病例与治疗相关的临床病理和免疫学变化:一项回顾性研究。
Biomed Res Int. 2015;2015:745062. doi: 10.1155/2015/745062. Epub 2015 May 18.
3
Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan.苏丹境内治疗性策略治疗黑热病后皮肤利什曼病患者。
J Trop Med. 2013;2013:708391. doi: 10.1155/2013/708391. Epub 2013 Apr 15.
4
Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.基于利什曼原虫前鞭毛体膜抗原的酶联免疫吸附测定和免疫印迹法用于印度黑热病后皮肤利什曼病的鉴别诊断
J Clin Microbiol. 2005 Mar;43(3):1269-77. doi: 10.1128/JCM.43.3.1269-1277.2005.
5
Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.聚合酶链反应用于诊断黑热病后皮肤利什曼病。
J Clin Microbiol. 1998 Jun;36(6):1621-4. doi: 10.1128/JCM.36.6.1621-1624.1998.